The anabaptist washt and washt, and shrunk in the washing: John Gibbs's Baptismal controversies with Richard Carpenter and Richard Davis, c. 1652 and 1691-2LEWIS, Marilyn.Journal of the United Reformed Church History Society. 2001, Vol 6, Num 9, pp 632-641, issn 0049-5433, 10 p.Article

Library outreach services at a scientific meeting of the caribbean health research councilDRAYTON-ANDREWS, Marilyn; LEWIS, Marilyn.Journal of electronic resources in medical libraries. 2005, Vol 2, Num 4, pp 19-30, issn 1542-4065, 12 p.Article

Contingency management treatments that reinforce completion of goal-related activities : Participation in family activities and its association with outcomesLEWIS, Marilyn W; PETRY, Nancy M.Drug and alcohol dependence. 2005, Vol 79, Num 2, pp 267-271, issn 0376-8716, 5 p.Article

Population-Based Sequencing of the V3-loop Can Predict the Virological Response to Maraviroc in Treatment-Naive Patients of the MERIT TrialMCGOVERN, Rachel A; THIELEN, Alexander; JAMES, Ian et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 3, pp 279-286, issn 1525-4135, 8 p.Article

Mutations in gp41 are correlated with coreceptor tropism but do not improve prediction methods substantiallyTHIELEN, Alexander; LENGAUER, Thomas; SWENSON, Luke C et al.Antiviral therapy (London). 2011, Vol 16, Num 3, pp 319-328, issn 1359-6535, 10 p.Article

Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entryWESTBY, Mike; SMITH-BURCHNELL, Caroline; MORI, Julie et al.Journal of virology. 2007, Vol 81, Num 5, pp 2359-2371, issn 0022-538X, 13 p.Article

Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studiesMCGOVERN, Rachel A; THIELEN, Alexander; HARRIGAN, P. Richard et al.AIDS (London). 2010, Vol 24, Num 16, pp 2517-2525, issn 0269-9370, 9 p.Article

Characterization of Resistance to the Nonnucleoside NS5B Inhibitor Filibuvir in Hepatitis C Virus-Infected PatientsTROKE, Philip J. F; LEWIS, Marilyn; SIMPSON, Paul et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 3, pp 1331-1341, issn 0066-4804, 11 p.Article

Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencingARCHER, John; BRAVERMAN, Michael S; TAILLON, Bruce E et al.AIDS (London). 2009, Vol 23, Num 10, pp 1209-1218, issn 0269-9370, 10 p.Article

The effects of technology on midcareer librariansLEWIS, Marilyn P.Library trends. 2002, Vol 50, Num 4, pp 717-724, issn 0024-2594Article

Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078PORTSMOUTH, Simon; RAO VALLURI, Srinivas; HEERA, Jayvant et al.Antiviral research. 2013, Vol 97, Num 1, pp 60-65, issn 0166-3542, 6 p.Article

Genotypic Analysis of the V3 Region of HIV from Virologic Nonresponders to Maraviroc-Containing Regimens Reveals Distinct Patterns of FailureSWENSON, Luke C; CHUI, Celia K. S; JAMES, Ian et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 6122-6130, issn 0066-4804, 9 p.Article

Baseline CD4⁺ T―cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment―experienced patientsSCHAPIRO, Jonathan M; BOUCHER, Charles Ab; PERROS, Manos et al.Antiviral therapy (London). 2011, Vol 16, Num 3, pp 395-404, issn 1359-6535, 10 p.Article

Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced PatientsSWENSON, Luke C; MO, Theresa; HEERA, Jayvant et al.The Journal of infectious diseases. 2011, Vol 203, Num 2, pp 237-245, issn 0022-1899, 9 p.Article

Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of MaravirocSWENSON, Luke C; MO, Theresa; LEWIS, Marilyn et al.Clinical infectious diseases. 2011, Vol 53, Num 7, pp 732-742, issn 1058-4838, 11 p.Article

Emergence of CXCR4-Using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-Using virus reservoirWESTBY, Mike; LEWIS, Marilyn; WHITCOMB, Jeannette et al.Journal of virology. 2006, Vol 80, Num 10, pp 4909-4920, issn 0022-538X, 12 p.Article

Group-Based Randomized Trial of Contingencies for Health and Abstinence in HIV PatientsPETRY, Nancy M; WEINSTOCK, Jeremiah; ALESSI, Sheila M et al.Journal of consulting and clinical psychology. 2010, Vol 78, Num 1, pp 89-97, issn 0022-006X, 9 p.Article

Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 monthsLEWIS, Marilyn W; MISRA, Sonya; JOHNSON, Helen L et al.The American journal of drug and alcohol abuse. 2004, Vol 30, Num 2, pp 299-320, issn 0095-2990, 22 p.Article

Cocaine-Exposed Infant Behavior During Still-Face : Risk Factor AnalysesLEWIS, Marilyn W; PHILLIPS, Gary; BOWSER, Melissa et al.American journal of orthopsychiatry. 2009, Vol 79, Num 1, pp 60-70, issn 0002-9432, 11 p.Article